A Year After Parntering with iota, Astellas Snaps Up the Company

By cineramaOctober 15, 2020Altcoins

BalkansCat/Shutterstock

Astellas Pharma is building on a 2019 collaborative relationship and snapping up California-based iota Biosciences and that company’s bioelectronics technology in order to accelerate its Rx+ business.

Bioelectronic […]

Click here to view full article

Disclaimer

The statements, opinions and data contained on this site are solely those of the individual authors and contributors and not of the publisher of www.bitcoinisle.com. All content provided herein our website, hyperlinked sites, associated applications, forums, blogs, social media accounts and other platforms (“Site”) is for your general information only, procured primarily from third party sources. We make no warranties of any kind in relation to our content and services, including but not limited to accuracy, security and updatedness. No part of the content and services that we provide constitutes financial advice, legal advice or any other form of advice. Any use or reliance on our content and services is solely at your own risk and discretion. You should conduct your own research, review, analyze and verify our content and services before relying on or using them. Participating in cryptocurrency activities is a highly risky endeavor, please therefore consult your financial advisor before making any monetary decisions. No content on our Site is meant to be a solicitation or offer.

A Year After Parntering with iota, Astellas Snaps Up the Company

Tags:

Breaking News…

Previous PostIOTA Foundation Announces the Alpha Release for IOTA Streams for Users’ Ultimate Control Over Their Own Data

Next PostAstellas betting up to $429M on bioelectronics startup Iota Biosciences

Leave a Reply

Disclaimer